Refine by MP, party, committee, province, or result type.

Results 1-15 of 16
Sorted by relevance | Sort by date: newest first / oldest first

Subcommittee on Neurological Disease committee  Yes, certainly money is an issue, but it's the role of the federal government to support research. There it's not a matter of an issue with a government of a province. There, to have a national strategy in terms of the research component, in addition to guidelines, certainly it's

November 30th, 2010Committee meeting

Dr. Rémi Quirion

Subcommittee on Neurological Disease committee  Yes, in the field of Alzheimer's disease, there will be five times as much as that left on the table. What's left on the table, and we should probably say that this is in the excellent category, because below that we don't want to necessarily fund, there are certainly some excell

November 30th, 2010Committee meeting

Dr. Rémi Quirion

Subcommittee on Neurological Disease committee  No. The excellent category I would say would be about 25%. There are maybe 10% of grants that are not funded that should be funded.

November 30th, 2010Committee meeting

Dr. Rémi Quirion

Subcommittee on Neurological Disease committee  Five teams have been funded in the context of the partnership between Quebec, Canada, and France. Some are working on the role of prions, a protein, in diseases of the brain. It's based in Vancouver, with some people in Quebec and some people in France. Then there are other anima

November 30th, 2010Committee meeting

Dr. Rémi Quirion

Subcommittee on Neurological Disease committee  Most scientists who will be successful, people we have referred to here, will have at least three to four grants from CIHR, and then grants from the Alzheimer's Society of Canada. Often they will have some grants from the United States. To be able to properly run a lab in Canada,

November 30th, 2010Committee meeting

Dr. Rémi Quirion

Subcommittee on Neurological Disease committee  Maybe just to add a little bit, this group at McGill, in partnership with a group at Harvard, has a large grant from the U.S. army to try to test this drug, this beta blocker, in the treatment of PTSD. Hopefully we'll have a response on a fairly large cohort of subjects very soon

November 30th, 2010Committee meeting

Dr. Rémi Quirion

Subcommittee on Neurological Disease committee  Yes, football players and those in other types of sports have a lot of head injuries, and we know that head injuries are a factor in the development of Alzheimer's-type dementia. So the head injury part is not a good thing for boxers or for football players and so on. When we t

November 30th, 2010Committee meeting

Dr. Rémi Quirion

Subcommittee on Neurological Disease committee  The Alzheimer Society of Canada is part of the coalition that Inez talked about, and it is a partner with us. We are working very closely with them in developing the international strategy that I talked about. The numbers they have are real. We all mentioned them, so it's billion

November 30th, 2010Committee meeting

Dr. Rémi Quirion

Subcommittee on Neurological Disease committee  I think, in a sense, I'm in agreement with what others have mentioned, and that's to create a very strong network of Canadian experts, to have core centres in the country that will be expert in clinical research related to Alzheimer's disease and dementia; an animal model; brain

November 30th, 2010Committee meeting

Dr. Rémi Quirion

Subcommittee on Neurological Disease committee  Yes. It would be a bit like in the United States, where they have now 28 of these Alzheimer's disease centres. Each of them is funded to the level of about $8 million to $10 million a year. We don't necessarily ask for that in Canada, but each of these centres should have at leas

November 30th, 2010Committee meeting

Dr. Rémi Quirion

Subcommittee on Neurological Disease committee  Basically, some of them will be a bit more virtual. Others, such as where Weihong Song is, could be physical. At McGill, it could be physical because we have a node of people who are able to look at Alzheimer's disease from different perspectives. But in other places, like here i

November 30th, 2010Committee meeting

Dr. Rémi Quirion

Subcommittee on Neurological Disease committee  There are three other things that are also, of course, very important. We need to have a training ground to train the next generation of scientists and clinicians in the field of brain research, and in this case Alzheimer's disease. That is very important. Weihong here is very

November 30th, 2010Committee meeting

Dr. Rémi Quirion

Subcommittee on Neurological Disease committee  Well, in Canada at the moment, at the Canadian Institutes of Health Research, the average grant is about $120,000 per year. And usually this is for five years. Most of the grants are five-year grants.

November 30th, 2010Committee meeting

Dr. Rémi Quirion

Subcommittee on Neurological Disease committee  If we compare it with the U.S., the model is a bit different, but there it would be twice as much as that. That gives you the figure. I think if we were able to go to what we call an individual grant, at $200,000 per year for five years--so a block grant of $1 million for an in

November 30th, 2010Committee meeting

Dr. Rémi Quirion

Subcommittee on Neurological Disease committee  If you want me to start on a wish list, my wish list is quite long.

November 30th, 2010Committee meeting

Dr. Rémi Quirion